...
首页> 外文期刊>Archives of dermatological research. >Assessment of TGF-beta1-mediated growth inhibition of HPV-16- and HPV-18-transfected foreskin keratinocytes during and following immortalization.
【24h】

Assessment of TGF-beta1-mediated growth inhibition of HPV-16- and HPV-18-transfected foreskin keratinocytes during and following immortalization.

机译:在永生化期间和之后评估TGF-β1介导的HPV-16和HPV-18转染的包皮角质形成细胞的生长抑制。

获取原文
获取原文并翻译 | 示例

摘要

The responsiveness to transforming growth factor-beta1 (TGF-beta1) of two human keratinocyte cell lineages (FK16A and FK18B) generated after transfection with HPV-16 and HPV-18, respectively, was investigated. Both cell lineages revealed loss of heterozygosity (LOH) at 18q and/or 3p associated with the acquisition of the immortal phenotype. These loci harbour genes (TGF-beta receptor II gene at 3p, and Smad2 and Smad4 genes at 18q) encoding products involved in the TGF-beta1 signalling pathway. Mortal and early immortal stages of both cell lineages displayed growth reduction upon exposure to TGF-beta1 concentrations in the range 100 pg/ml to 1 ng/ml. However, the late immortal stages were resistant to TGF-beta1 at concentrations up to 10 ng/ml. TGF-beta1 receptors type I and II were expressed at all stages in both cell lineages. Moreover, mRNA levels of Smad2 and Smad4 genes were nearly constant throughout. TGF-beta1 expression and secretion, which were demonstrated in all analysed stages, may provide selective conditions underlying unresponsiveness to TGF-beta1 upon prolonged monolayer culturing. Thus, LOH at 3p and/or 18q seen during HPV-mediated immortalization of human keratinocytes was not associated with resistance to TGF-beta1-mediated growth inhibition or a marked reduction in TGF- beta1 receptors and mRNA levels of Smad2 or Smad4. Therefore, alternative events are likely to underlie unresponsiveness to TGF- beta1 in late-passage FK16A and FK18B cells.
机译:研究了分别用HPV-16和HPV-18转染后产生的两个人角质形成细胞谱系(FK16A和FK18B)对转化生长因子β1(TGF-β1)的响应性。两种细胞谱系均显示与永生表型的获得有关的18q和/或3p杂合性(LOH)丧失。这些位点包含编码参与TGF-beta1信号通路的产物的基因(3p处为TGF-β受体II基因,而18q处为Smad2和Smad4基因)。当暴露于100 pg / ml至1 ng / ml范围的TGF-beta1浓度时,两种细胞谱系的致死期和早期永生期均显示出生长减少。然而,永生后期对浓度高达10 ng / ml的TGF-beta1具有抗性。 TGF-beta1 I型和II型受体在两种细胞谱系的所有阶段均表达。此外,Smad2和Smad4基因的mRNA水平始终保持恒定。在所有分析阶段均证实了TGF-beta1的表达和分泌,可能提供了在长期单层培养后对TGF-beta1无反应的选择性条件。因此,在HPV介导的人类角质形成细胞永生化过程中观察到的3p和/或18q处的LOH与对TGF-β1介导的生长抑制的抗性或TGF-β1受体和Smad2或Smad4的mRNA水平的显着降低无关。因此,替代事件可能是晚传代FK16A和FK18B细胞对TGF-β1无反应的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号